HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.

Wang SV, Pottegård A, Crown W, Arlett P, Ashcroft DM, Benchimol EI, Berger ML, Crane G, Goettsch W, Hua W, Kabadi S, Kern DM, Kurz X, Langan S, Nonaka T, Orsini L, Perez-Gutthann S, Pinheiro S, Pratt N, Schneeweiss S, Toussi M, Williams RJ

Open source

DOI: 10.1002/pds.5507
Published: 2023 Jan
Container: Pharmacoepidemiology and drug safety
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/pds.5507,
  title = {HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.},
  author = {Wang SV and Pottegård A and Crown W and Arlett P and Ashcroft DM and Benchimol EI and Berger ML and Crane G and Goettsch W and Hua W and Kabadi S and Kern DM and Kurz X and Langan S and Nonaka T and Orsini L and Perez-Gutthann S and Pinheiro S and Pratt N and Schneeweiss S and Toussi M and Williams RJ},
  year = {2023},
  journal = {Pharmacoepidemiology and drug safety},
  doi = {10.1002/pds.5507},
  url = {https://doi.org/10.1002/pds.5507}
}

RIS

TY  - JOUR
TI  - HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
AU  - Wang SV
AU  - Pottegård A
AU  - Crown W
AU  - Arlett P
AU  - Ashcroft DM
AU  - Benchimol EI
AU  - Berger ML
AU  - Crane G
AU  - Goettsch W
AU  - Hua W
AU  - Kabadi S
AU  - Kern DM
AU  - Kurz X
AU  - Langan S
AU  - Nonaka T
AU  - Orsini L
AU  - Perez-Gutthann S
AU  - Pinheiro S
AU  - Pratt N
AU  - Schneeweiss S
AU  - Toussi M
AU  - Williams RJ
PY  - 2023
JO  - Pharmacoepidemiology and drug safety
DO  - 10.1002/pds.5507
UR  - https://doi.org/10.1002/pds.5507
ER  -

APA

SV, W., A, P., W, C., P, A., DM, A., EI, B., ML, B., G, C., W, G., W, H., S, K., DM, K., X, K., S, L., T, N., L, O., S, P., S, P., N, P., S, S., M, T., & RJ, W. (2023). HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.5507

Source records

pubmed · retrieved 2026-09-25T02:48:16.971Z